FDA grants fast track designation to Onivyde for advanced ... | 合法藥品大搜索

2020年6月17日—“SincetheinitialapprovalofOnivydeinmetastaticpancreaticcancer,wehavecontinuedtodedicateourresearcheffortstobetterunderstand ...

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on . Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected][1].

Back to Healio

The FDA granted fast track designation to liposomal irinotecan as part of a first-line combination for the treatment of adults with previously untreated, unresectable, locally advanced and metastatic pancreatic ductal adenocarcinoma.

This indication applies to the use of lipo...

Onivyde (irinotecan liposome injection) for the Treatment of ... | 合法藥品大搜索

Metastatic Pancreatic Cancer Treatment Option | 合法藥品大搜索

ONIVYDE (irinotecan liposome injection) is proven to help people with metastatic pancreatic cancer, who previously received gemcitabine chemotherapy, live ... Read More

Liposomal Irinotecan | 合法藥品大搜索

由 JE Frampton 著作 · 2020 · 被引用 4 次 — Key words were liposomal irinotecan, Onivyde, pancreatic cancer. Records were limited to those in ... Read More

FDA grants fast track designation to Onivyde for advanced ... | 合法藥品大搜索

2020年6月17日 — “Since the initial approval of Onivyde in metastatic pancreatic cancer, we have continued to dedicate our research efforts to better understand ... Read More

Pancreatic Cancer Study Program – National Institute of ... | 合法藥品大搜索

ONIVYDETM. One of the most exciting achievement of NICR in the past years is the success of a global, randomized phase III NAPOLI- ... Read More

NAPOLI | 合法藥品大搜索

由 A Wang-Gillam 著作 · 2019 · 被引用 65 次 — Longer overall survival in metastatic pancreatic cancer post–first line ... Liposomal irinotecan (nal-IRI; Onivyde®; Ipsen Biopharmaceuticals, Inc. Read More

Onivyde (Irinotecan Liposome Injection) a New Treatment ... | 合法藥品大搜索

由 LA Raedler 著作 · 被引用 1 次 — The FDA approval of irinotecan liposome injection has added a new treatment option for patients with pancreatic cancer. The drug is only approved for use in ... Read More

Ipsen receives FDA Fast Track designation for liposomal ... | 合法藥品大搜索

2020年6月17日 — “Since the initial approval of ONIVYDE® in metastatic pancreatic cancer, we have continued to dedicate our research efforts to better ... Read More

The safety and efficacy of Onivyde (irinotecan liposome ... | 合法藥品大搜索

由 FC Passero Jr 著作 · 2016 · 被引用 61 次 — Introduction: Patients with advanced and metastatic pancreatic cancer refractory to gemcitabine based therapy have a dismal prognosis and limited therapeutic ... Read More

Liposomal Irinotecan Regimen Pushes Toward Frontline ... | 合法藥品大搜索

2020年8月18日 — ... the NAPOLI-1 and NAPOLI-3 trials in metastatic pancreatic cancer, ... In October 2015, the FDA approved liposomal irinotecan (Onivyde) in ... Read More

相關資訊整理